Inventors: Bastiaan Nuijen, Jacob Hendrik. Nuijen B, Schumacher. Bastiaan Nuijen;. Bastiaan Nuijen. A. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Nuijen, Bastiaan2. van den Slotervaart Hospital) for assistance and C. , Donald R. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. ,. Bastiaan Nuijen. Sjoerd Rodenhuis MD PhD. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. All freeze-dried products. Click to explore. Bastiaan Nuijen. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Assignees: Slotervaart Participaties BV,. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. M. , Hendrikx JJMA; Department of Pharmacy. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. Authors. About Nuijen Bastiaan. NL EC. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. Pharmacy & Pharmacology, Louwesweg, 6,. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. M. Nuijen. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. Affiliations. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. 1. , Bas Thijssen b. Bastiaan Nuijen a, Martine T. . 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Schellens & Jos H. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. View author publications. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Stewart. M. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Beijnen. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Beste Gert, hoewel ik ver weg in. Marchetti (1), Jos H. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. Search ""; Search. About Department Nuijen Bastiaan. J Control Release. Means and methods for breaking noncovalent binding. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. The Netherlands c Department of Clinical Pharmacy. Beijnen. Bastiaan Nuijen [HOST], Ph. Bastiaan Nuijen;. Nuijen B, Bouma M, Henrar REC, et al. Page Chapter Abstract. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Beijnen (2,3), Jan H. Schellens & Jos H. Bastiaan Nuijen. NL EC. 2. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. Nuijen B, Bouma M, Henrar REC, et al. , Hilde Rosing b. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. View author publications. f, Ruben Schouten M. Bastiaan Nuijen. Department. D. Beijnen. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). D. Jan Moes, Amsterdam (NL); Bastiaan. . 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Authors. NUIJEN, Bastiaan. Slotervaart Hospital, Amsterdam, the Netherlands; 3. Lamers (Erasmus MC, Rotterdam). dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. B. Slotervaart Hospital/The Netherlands. Affiliations. , Ph. Nederlands. van der Schoot, Bastiaan Nuijen & Jos H. and Gert Storm. , Marianne Keessen a,e Slotervaart, Amsterdam,. You can also search for this author in. Jan 25;(2) dna tattoo. Pharmacy & Pharmacology, Louwesweg, 6,. (Bastiaan Nuijen), we have. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. Olaciregui-Ruiz, Igor. H. en naar mijn copromotor Bastiaan Nuijen. Bastiaan Nuijen. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. M. V. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. You can also search for this author in. Amsterdam (NL); Stichting Het. Department of. Beijnen (2,3). Bastiaan Nuijen b. Bastiaan Nuijen. Oncology B. Shannon. NUIJEN, Bastiaan. [HOST]@[HOST] Pharmazie – (). 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. g, Ruben N. View. , Kevin F. Beijnen. van den Berg, Bastiaan Nuijen,. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. D. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. Faculty of. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. TN, Haanen JB, Storm G, Beijnen JH,. Nuijen, Amsterdam (NL). Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Bastiaan Nuijen. over the past year Slotervaart Hospital) and Wim Hennink. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. Beijnen (2,3). Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. Bastiaan Nuijen, PhD. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. Bastiaan Nuijen,; Jos H. Bastiaan Nuijen, Marjan Bouma, Jan H.